Potentially harmful excipients in neonatal medicines: A pan-European observational study

Archives of Disease in Childhood

Volumn 100, Issue 7, 2015, Pages 694-699

  Nellis, Georgi ^a,b   Metsvaht, Tuuli ^a,b   Varendi, Heili ^b   Toompere, Karolin ^a   Lass, Jana ^a,b   Mesek, Inge ^a   Nunn, Anthony J ^c   Turner, Mark A ^d,e   Lutsar, Irja ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^d LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ALCOHOL; AMPICILLIN; BENZALKONIUM CHLORIDE; BENZOIC ACID DERIVATIVE; CARNITINE; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOMPERIDONE; EXCIPIENT; FILGRASTIM; GENTAMICIN; IRON; LINCOMYCIN; MEROPENEM; METRONIDAZOLE; PANCURONIUM; PENICILLIN G; PHYTOMENADIONE; POLYSORBATE 80; PROPYLENE GLYCOL; SACCHARIN SODIUM; SORBITOL; TEICOPLANIN; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ARTICLE; EXPOSURE; GEOGRAPHIC DISTRIBUTION; GESTATIONAL AGE; HOSPITAL PATIENT; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICINE; MULTICENTER STUDY; NEWBORN; NEWBORN CARE; OBSERVATIONAL STUDY; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG SUBSTITUTION; DRUG UTILIZATION; EUROPE; HOSPITALIZATION; NEWBORN INTENSIVE CARE; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG SUBSTITUTION; DRUG UTILIZATION; EUROPE; EXCIPIENTS; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; RISK FACTORS;

EID: 84933177366     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2014-307793     Document Type: Article

References (34)

1. Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res 2011;63:362-5.
2. Golightly LK, Smolinske SS, Bennett ML, et al. Pharmaceutical Excipients. Med Toxicol Adverse Drug Exp 2012;3:128-65.
3. DeMerlis CC, Goldring JM, Ranga Velagaleti P, et al. Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure. Pharm Technol 2009;33:72-82.
4. Pifferi G, Restani P. The safety of pharmaceutical excipients. Farm 2003;58:541-50.
5. De Cock RFW, Knibbe CAJ, Kulo A, et al. Developmental pharmacokinetics of propylene glycol in preterm and term neonates. Br J Clin Pharmacol 2013;75:162-71.
6. Warner A. Drug use in the neonate: interrelationships of pharmacokinetics, toxicity, and biochemical maturity. Clin Chem 1986;32:721-7.
7. European Medicines Agency. Guideline on pharmaceutical development of medicines for paediatric use. 2013:1-24. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2013/07/WC500147002.pdf
8. European Medicines Agency. Guideline on the investigation of medicinal products in the term and preterm neonate. 2009:1-21. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003754.pdf
9. th edn. Pharmaceutical Press and American Pharmacists Association, 2012.
10. Hanke U, May K, Rozehnal V, et al. Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). Eur J Pharm Biopharm 2010;76:260-8.
11. European Commission. Excipients in the label and package leaflet of medicinal products for human use. 2003;3B. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003412.pdf
12. Nahata MC. Safety of "inert" additives or excipients in paediatric medicines. Arch Dis Child Fetal Neonatal Ed 2009;94:F392-3.
13. European Medicines Agency. Questions & answers on propylene glycol and esters in the context of the revision of the guideline on " Excipients in the label and package leaflet of medicinal products for human use" (CPMP/463/00). 2014. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/12/WC500177945.pdf
14. European Medicines Agency. Reflection paper: formulations of choice for the paediatric population. Published Online First: 2006. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003782.pdf (accessed 11 Dec2012).
15. European Medicines Agency. Questions and Answers on Ethanol in the context of the revision of the guideline on "Excipients in the label and package leaflet of medicinal products for human use" (CPMP/463/00) Draft. 2014. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/02/WC500162033.pdf
16. European Medicines Agency. Reflection paper on the use of methyl- and propylparaben as excipients in human medicinal products for oral use. 2013:1-11. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2013/05/WC500143139.pdf
17. Hiller JL, Benda GI, Rahatzad M, et al. Benzyl alcohol toxicity: impact on mortality and intraventricular hemorrhage among very low birth weight infants. Pediatrics 1986;77:500-6. http://pediatrics.aappublications.org/content/77/4/500
18. European Medicines Agency. Questions and Answers on Benzoic acid and Benzoates in the context of the revision of the guideline on " Excipients in the label and package leaflet of medicinal products for human use" (CPMP/463/00). 2014. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/02/WC500162031.pdf
19. European Medicines Agency. Questions and Answers on Benzyl alcohol in the context of the revision of the guideline on " Excipients in the label and package leaflet of medicinal products for human use " (CPMP/463/00). 2014. http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2014/02/WC500162032.pdf
20. Ursino MG, Poluzzi E, Caramella C, et al. Excipients in medicinal products used in gastroenterology as a possible cause of side effects. Regul Toxicol Pharmacol 2011;60:93-105.
21. Duro D, Rising R, Cedillo M, et al. Association between infantile colic and carbohydrate malabsorption from fruit juices in infancy. Pediatrics 2002;109:797-805.
22. Whittaker A, Currie AE, Turner MA, et al. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F236-40.
23. Shehab N, Lewis CL, Streetman DD, et al. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit care Med 2009;10:256-9.
24. Lass J, Naelapää K, Shah U, et al. Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr 2012;12:136.
25. Souza A, Santos D, Fonseca S, et al. Toxic excipients in medications for neonates in Brazil. Eur J Pediatr 2014;173:935-45.
26. Nellis G, Lutsar I, Varendi H, et al. Comparison of two alternative study designs in assessment of medicines utilisation in neonates. BMC Med Res Methodol 2014;14:89.
27. Turner MA, Duncan JC, Shah U, et al. Risk assessment of neonatal excipient exposure: Lessons from food safety and other areas. Adv Drug Deliv Rev 2014;73C:89-101.
28. Stark AR. Levels of neonatal care. Pediatrics 2004;114:1341-7.
29. Modi N. Categories of Care 2011. London, UK: 2011. http://www.bapm.org/publications/documents/guidelines/CatsofcarereportAug11.pdf
30. United Nations Statistics Division - composition of macro geographical (continental) regions, geographical sub-regions, and selected economic and other groupings. 2012. http://unstats.un.org/unsd/methods/m49/m49regin.htm#europe (accessed 13 Dec 2012).
31. WHO | Preterm birth. 2013. http://www.who.int/mediacentre/factsheets/fs363/en/ (accessed 19 Dec 2013).
32. Walsh J, Cram A, Woertz K, et al. Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev 2014;73:14-33.
33. Mulla H, Yakkundi S, McElnay J, et al. An observational study of blood concentrations and kinetics of methyl- and propyl-parabens in neonates. Pharm Res 2015;32:1084-93.
34. Salunke S, Brandys B, Giacoia G, et al. The STEP (Safety and Toxicity of Excipients for Paediatrics) database: Part 2 - The pilot version. Int J Pharm 2013;457:310-22.